IBRO Neuroscience Reports (Oct 2023)
OPTIMIZATION AND EVALUATION OF PYRIDINYL VINYL SULFONES AS NRF2 ACTIVATOR FOR THE ANTIOXIDANT AND ANTI-INFLAMMATORY EFFECTS
- Rium Kim,
- Byungeun Kim,
- Hyeon Jeong Kim,
- Yoowon Kim,
- Sun Jun Park,
- Elijah Lee,
- Jushin Kim,
- Jaehwan Kim,
- Ji Won Choi,
- Jong-Hyun Park,
- Ki Duk Park
Affiliations
- Rium Kim
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; University of Science & Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Byungeun Kim
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; University of Science & Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Hyeon Jeong Kim
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of
- Yoowon Kim
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; Yonsei University, Department Of Biotechnology, College Of Life Science And Biotechnology, Seoul, Korea, Republic of
- Sun Jun Park
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; Cureverse, Co., Ltd., Drug Discovery, Seoul, Korea, Republic of
- Elijah Lee
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; University of Science & Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Jushin Kim
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; Yonsei University, Department Of Biotechnology, College Of Life Science And Biotechnology, Seoul, Korea, Republic of
- Jaehwan Kim
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; University of Science & Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Ji Won Choi
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; Cureverse, Co., Ltd., Drug Discovery, Seoul, Korea, Republic of
- Jong-Hyun Park
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; University of Science & Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Ki Duk Park
- Korea Institute of Sience and Technology, Center For Brain Disoders, Seoul, Korea, Republic of; University of Science & Technology, Division Of Bio-medical Science & Technology, Kist School, Seoul, Korea, Republic of
- Journal volume & issue
-
Vol. 15
p. S434
